Clinical Trial Update: Antigen-Specific Cell Mediated Immune Response to Chlamydia Trachomatis

View source ↗

Summary

A completed University of Pittsburgh clinical trial investigating antigen-specific cell-mediated immune responses to Chlamydia trachomatis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chlamydia

Snippet

Sponsor: University of Pittsburgh | Conditions: Chlamydia | Status: COMPLETED